Original Source(s)
Related Content
FDA clears targeted cholangiocarcinoma therapy
In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.
September 24, 2026
-
2 min
How does IBD relate to joint infection risk?
Investigators assessed 90-day outcomes among patients with IBD who underwent elective total joint arthroplasty.
August 31, 2026
-
4 min
Medical Oddities: A fowl cause of urinary obstruction
A rogue chicken bone, stalled sweat, yoga for IBS, and L-theanine for sleep is break room fodder this week.
by Teraya Smith
September 10, 2026
-
5 min
